Discovery of GSBR-1290, a Highly Potent, Orally Available, Novel Small Molecule GLP-1 Receptor Agonist

被引：1
|
作者：
Mao, Ting
Meng, Qinghua
Zhang, Haizhen
Zhang, Jinqiang J.
Shi, Songting
Guan, Zhibo
Jiang, Xinglong
Zhang, Fang
Lei, Hui
Lin, Xichen
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-760-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
760-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A First-in-Human Single Ascending Dose Study of GSBR-1290, a Novel Small Molecule GLP-1 Receptor Agonist, in Healthy Volunteers
    Coll, Blai
    Zhang, Jinqiang J.
    Jacober, Scott J.
    Argent, Christopher
    Ibarra, Lani
    Snyder, Margo
    Bach, Mark A.
    DIABETES, 2023, 72
  • [2] Discovery of Nonpeptide, Orally Available Small Molecule GLP-1 Receptor Agonists
    Im, A-Rang
    Park, Jung-Eun
    Hong, Dahae
    Je, In-Gyu
    Kim, Jung Ho
    Chang, Min Whan
    Hong, Chang-Hee
    Shin, Jae Eui
    Sohn, Te-Ik
    Jun, Yearin
    Jang, Eunhye
    Yoo, Yeongran
    Jeon, Woojin
    An, Kyungmi
    DIABETES, 2021, 70
  • [3] Drug Design Principles and Pharmacokinetics/Pharmacodynamics of GSBR-1290, a Small Molecule GLP-1RA
    Liu, Ke
    Barriere, Olivier
    de la Pena, Amparo
    Teruel, Carlos Fernandez
    Seman, Leo
    Coll, Blai
    Yue, Huibin
    Bach, Mark
    Barth, Aline
    OBESITY, 2024, 32 : 189 - 189
  • [4] Discovery of a Potent, Orally Efficacious Small Molecule Agonist of Glucagon-Like Peptide-1 (GLP-1) Receptor
    Bearss, David J.
    Lin, Chenyu
    Medley, Kyle
    Vankayalapati, Hariprasad
    DIABETES, 2024, 73
  • [5] Significant and Clinically Relevant Weight Changes at 12 Weeks With Small Molecule GLP-1RA,GSBR-1290
    Seman, Leo
    Yue, Huibin
    Liu, Ke
    Barth, Aline
    Chari, Divya
    Pelayo, Michael
    Coll, Blai
    Bach, Mark
    OBESITY, 2024, 32 : 191 - 191
  • [6] Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
    Wang, Qinghua
    Chen, Kui
    Liu, Rui
    Zhao, Fang
    Gupta, Sandeep
    Zhang, Nina
    Prud'homme, Gerald J.
    PLOS ONE, 2010, 5 (09): : 1 - 9
  • [7] HD-7671, a Nonpeptide Small Molecule for Orally Available GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion
    Baek, Myoungki
    Kim, Daehoon
    Kim, Chun Hwa
    Kim, Doo Young
    Choi, Hyo Sun
    Kang, Seung Jun
    Lee, Hankyu
    Lee, Kyuhwan
    DIABETES, 2020, 69
  • [8] ZYOG1, A Novel Orally Efficacious Peptidomimetic GLP-1 Receptor Agonist
    Jain, Mukul R.
    Bahekar, Rajesh
    Joharapurkar, Amit
    Bandhyopadhyay, Debdutta
    Sundar, Rajesh
    Patel, Harilal
    Pawar, Vishwanath
    DIABETES, 2012, 61 : A16 - A16
  • [9] Discovery of ID110521156, a Small Molecule GLP-1 Receptor Agonist, for the Treatment of Type 2 Diabetes and Obesity
    Je, In-Gyu
    Im, A-Rang
    Lee, Don-Gil
    Choi, Won-Gu
    Jang, Eunhye
    Park, Ji-Soo
    Kim, Dohee
    Lee, Jungwoo
    Park, Joontae
    An, Kyungmi
    Yoon, Hongchul
    Kim, Ki-Young
    Choi, Sungku
    DIABETES, 2023, 72
  • [10] Discovery of potent and orally available small molecule inhibitors of the SOS1-KRAS interaction
    Yu, Ha Na
    Ki, Dong Hyuk
    Nam, Joonwoo
    Kim, Eun-Jung
    Kim, Sungeun
    Choi, Hunmi
    Kim, Jieun
    Yu, Jihyun
    Kim, Donggeon
    Park, Dohyun
    Yoon, Kyeong Jin
    Jo, Seongin
    Hwang, So-Hyeon
    Lim, Sang Kyun
    Shin, Young Sook
    Han, Wooseok
    CANCER RESEARCH, 2023, 83 (07)
12345